Duality Biotherapeutics, Inc. (9606.HK) stock price, financials & research

Regular session · HKT · Market data may be delayed.

Company profile

Operating as a clinical-stage enterprise, Duality Biotherapeutics, Inc. concentrates on pioneering next-generation antibody-drug conjugate (ADC) therapies and proprietary duality immune toxin antibody conjugate (ITAC) solutions. The firm was founded by Zhu Zhong Yuan on July 3, 2019, and its main offices are situated in Shanghai, China.

Industry: Biotechnology
Sector: Healthcare
Headquarters: CN
CEO: Zhongyuan Zhu
Listed since: Apr 15, 2025
Employees: 231

Market position

Day range

Current HK$191.5

HK$190HK$202.4

52-week range

Current HK$191.5

HK$158.5HK$563.5

Open: HK$195
Previous close: HK$194.5
Volume: 506.92K; 0.46× average
Average volume: 1.09M; Average daily volume
Market cap: 17.33B HKD
Beta: 1.42; Market reference 1
50-day average: HK$200.49; -4.48% below average
200-day average: HK$275.87; -30.58% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value: 16.27B CNY
P/E (TTM): -2.95×
P/B (TTM): 5.99×
P/S (TTM): 8.02×
EV / EBITDA: -6.47×
Earnings yield: -14.48%
Free cash flow yield: 1.04%
Dividend yield: 0.00%

Profitability & efficiency

Gross margin: 31.81%
Operating margin: -26.29%
Net margin: -140.13%
Return on equity: -104.12%
Return on assets: -64.90%
Return on invested capital: -13.93%

Financial health

Debt / equity: 0.06×
Current ratio: 3.61×
Altman Z-score: 4.96
Piotroski F-score: 3 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin

Income trends

Revenue

1.8B CNY-7.08%

Operating income

−416.27M CNY-120.26%

Net income

−2.53B CNY-140.63%

Metric (CNY)	FY2025	FY2024	FY2023	FY2022
Revenue	1.8B CNY	1.94B CNY	1.79B CNY	1.6M CNY
Cost of goods sold	1.24B CNY	1.16B CNY	427.66M CNY	—
Gross profit	561.85M CNY	784.67M CNY	1.36B CNY	1.6M CNY
Research and development	809.54M CNY	836.73M CNY	559M CNY	339.89M CNY
Selling, general, and administrative	168.57M CNY	39.78M CNY	36.67M CNY	15.09M CNY
Operating expenses	978.11M CNY	973.66M CNY	577.53M CNY	370.18M CNY
Interest income	96.74M CNY	48.11M CNY	34.48M CNY	3.27M CNY
Interest expense	1.18M CNY	250K CNY	188K CNY	75K CNY
Depreciation and amortization	12M CNY	7.87M CNY	4.99M CNY	1.8M CNY
Operating income	−416.27M CNY	−188.99M CNY	781.36M CNY	−368.58M CNY
Net income	−2.53B CNY	−1.05B CNY	−357.51M CNY	−387.09M CNY